Skip to content
DataLookout
Menu

Merck-4NCT07240220

The Mother-Daughter Project: Merck-4

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened Show 6 more changesShow less
    • Start date changed from estimate of Feb 1, 2026 to Jul 22, 2026
    • Eligibility criteria expanded, about 6 words
    • Primary endpoints: details revised at 1 of 4 entries
    • Interventions modified
    • Study description revised
    • Site details revised
  2. Notable Phase: Not specified to Not applicablev2 Show 7 more changesShow less
    • Primary completion date: Feb 1, 2028 to Aug 1, 2028
    • Eligibility criteria shortened, about 14 words
    • Primary endpoints: 1 to 4
    • Interventions: 9-valent HPV vaccine (Biological) to Gardisil-9 (Biological), High Risk HPV DNA Testing (Diagnostic Test), Visual Inspection with acetic acid (VIA) and possible cervical biopsy…
    • Study description shortened, about 4,008 words
    • Study title shortened, about 13 words
    • Study arms: 1 to 2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Detection of CIN2/3
Timeframe: Baseline
Local knowledge and attitudes
Timeframe: Baseline and after HPV vaccination of daughters is complete (assessed 2 weeks after second vaccine)
Barriers to participation
Timeframe: During a one-time interview
Factors that influence immunity to the HPV vaccine
Timeframe: 24 months after second HPV vaccine

Arms and interventions

Kenyan womenOther

Up to 500 adult women will undergo cervical cancer screening.

Kenyan daughtersOther

Up to an additional 2000 girls (daughters of participants in the Kenyan women arm) will be immunized against HPV using the 9-valent HPV vaccine (Gardasil-9).

Biologicals: Gardasil-9

Diagnostic tests: High Risk HPV DNA Testing

Procedures: Visual Inspection with acetic acid (VIA) and possible cervical biopsy

Sites

1 site in 1 country

  • Moi UniversityEldoret, Kenya